INOVIO PHARMACEUTICALS, INC.

INO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $-24.4M
Depreciation & Amortization
Depreciation $237.2K
Amortization $1.4M
Stock-Based Compensation $2.2M
Net Cash from Operating Activities $-14.1M
Investing Activities
Capital Expenditures $48.4K
Business Acquisitions
Net Cash from Investing Activities $1.4M
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $28.6M
Net Change in Cash $16.2M
Free Cash Flow $-14.1M
← Newer Page 3 of 3 Older →